Shuohao Shen

Dr. Shuohao Shen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
RLRuihua Li
Ruihua Li
SSShuohao Shen
Shuohao Shen
JJJianjun Jiang
Jianjun Jiang
YLYang Liu
Yang Liu

7 November 2023 in Research Square
Verified
Preprint
Open access
PDF file
JTJiayu Tan
Jiayu Tan
SSShuohao Shen
Shuohao Shen
Introduction: Cardio-oncology has received more and more attention in the older patients with colorectal cancer(CRC). We aimed to identify the prognostic factors and construct a nomogram-based model to predict the cardiovascular disease(CVD) mortality for the older patients with CRC.Materials and Methods: The data on the older patients diagnosed with CRC were retrieved from the SEER database from 2004 to 2015. The prognostic factors and a nomogram-based model predicting the CVD-specific mortality was performed by the Least absolute shrinkage and selection operator (LASSO) and Cox regression.Results: A total of 141251 eligible patients with CRC were enrolled, of which 41459 patients died of CRC and 12651 patients died of CVD. The age at diagnosis, sex, marital status, the year of diagnosis, surgery and chemotherapy were independent prognostic factors associated with CVD-specific mortality in the older patients with CRC. And we used these variables to develop the model predicting the CVD-specific mortality. The calibration curves for CVD-specific mortality probabilities showed that the model was in good agreement with actual observations. The C-index value of the model in the training cohort and testing cohort for predicting CVD-specific mortality was 0.728 and 0.734, respectively.Discussion: The proposed nomogram-based model of the CVD-specific mortality could be used to predict the accurate prognosis for the older patients with CRC. This model could be a useful tool for clinicians to identify high-risk patients and develop personalized treatment plans. The derived nomogram-based model could be adopted to assistant clinicians including oncologists and cardiologists to providing screening recommendations and choosing an optimum treatment regimen.

26 August 2024 in World Journal of Cardiology
Verified
Journal Article
Open access
JTJia-Yu Tan
Jia-Yu Tan
SSShuohao Shen
Shuohao Shen
BACKGROUND Cardio-oncology has received increasing attention especially among older patients with colorectal cancer (CRC). Cardiovascular disease (CVD)-specific mortality is the second-most frequent cause of death. The risk factors for CVD-specific mortality among older patients with CRC are still poorly understood. AIM To identify the prognostic factors and construct a nomogram-based model to predict the CVD-specific mortality among older patients with CRC. METHODS The data on older patients diagnosed with CRC were retrieved from The Surveillance, Epidemiology, and End Results database from 2004 to 2015. The prognostic factors and a nomogram-based model predicting the CVD-specific mortality were assessed using least absolute shrinkage and selection operator and Cox regression. RESULTS A total of 141251 eligible patients with CRC were enrolled, of which 41459 patients died of CRC and 12651 patients died of CVD. The age at diagnosis, sex, marital status, year of diagnosis, surgery, and chemotherapy were independent prognostic factors associated with CVD-specific mortality among older patients with CRC. We used these variables to develop a model to predict CVD-specific mortality. The calibration curves for CVD-specific mortality probabilities showed that the model was in good agreement with actual observations. The C-index value of the model in the training cohort and testing cohort for predicting CVD-specific mortality was 0.728 and 0.734, respectively. CONCLUSION The proposed nomogram-based model for CVD-specific mortality can be used for accurate prognostic prediction among older patients with CRC. This model is a potentially useful tool for clinicians to identify high-risk patients and develop personalized treatment plans.